Roche Holding AG Participation (ROGz)

363.22
-1.00(-0.28%)
  • Volume:
    344,874
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    361.25 - 367.15

ROGz Overview

Prev. Close
363.25
Day's Range
361.25-367.15
Revenue
-
Open
364.5
52 wk Range
293.15-378.95
EPS
-
Volume
344,874
Market Cap
332.48B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
284,142
P/E Ratio
-
Beta
-
1-Year Change
32.58%
Shares Outstanding
854,260,903
Next Earnings Date
Feb 03, 2022
What is your sentiment on Roche Holding AG Participation?
or
Market is currently closed. Voting is open during market hours.

Roche Holding AG Participation Company Profile

Employees
101465

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women’s health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. The company has collaboration with Gilead Sciences, Inc. for COVID-19; a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza, as well as SemaThera Inc. to develop biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases; and has collaboration with Affimed N.V to study AFM24 in combination with PD-L1 checkpoint inhibitor in EGFR expressing solid tumors, as well as with Surface Oncology, Inc. to evaluate SRF388. It also has a clinical collaboration with Carrick Therapeutics, Ltd. to evaluate a novel combination of Carrick’s samuraciclib and its giredestrant in CDK4/6i resistant HR+, HER2- metastatic breast cancer; a collaboration with Zur Rose Group AG to empower people with diabetes and their caregivers in their daily therapy management; and a research collaboration and license agreement with Venatorx Pharmaceuticals, Inc. to discover, characterize, and develop new small molecule inhibitors of the Penicillin Binding Proteins in Gram-negative bacteria focused on agents active against carbapenem-resistant Enterobacterales. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellSellStrong BuyStrong Buy
Technical IndicatorsSellStrong SellBuyNeutralStrong Buy
SummaryStrong SellStrong SellNeutralBuyStrong Buy
  • A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
    3
    • Trades ex dividend!!
      0
      • Currently near to Fibo 61.8 levels, a great company to buy IMO.
        0
        • Any comments?
          0
          • Still holding, not a good stock tho..
            2
        • cant make it even during pandemic, sell
          2
          • I've invested in Roche.VX, is it the right stock?
            0
            • Which one is the real Roche stock? I found out today that a big company in Germany is buying covid tests from Roche but i don't know for sure in which stock should i invest.  The stock will go surely up but i wanna be in the right one. I've invested in this one but i am not sure if it's the real one because i heard a rumour and they said that the tests are coming from FRANCE. If someone can help me understand, thank you.
              4
              • CH:ROG
                0
              • nevertheess, i would buy below 300. its probably gonna test there. roche is not perfoming at its best at the moment. when buy now the longterm ... because dividends are pretty good here. if you hold 20 years - the dividends would have paid you back the amount you spend now
                0
              • france = Sanofi is not Roche
                0
            • Roche : Rolls Out Coronavirus Antibody Test https://www.marketscreener.com/ROCHE-HOLDING-AG-9364975/news/Roche-Rolls-Out-Coronavirus-Antibody-Test-30637349/
              0
              • What is the different between RHHBY and RHHVF?
                0
                • This is presentaion for Q1 https://www.roche.com/dam/jcr:e489e27b-f777-4781-b112-70c0bbfc4bdf/en/irp200422-a.pdf
                  5
                  • im buying, this is going to be 600-700 this year
                    0
                    • Great solid Q1 Results and some nice info about Covid-19 Diagnosis Machines..
                      0
                      • is it now too late to buy more ?
                        1
                        • noup, this will go up much more
                          0
                      • Yall tripping i have 2 companies im investing in and this is one of them. They are gonna supply americans and maybe the world with test kits for the virus. This alone will bring their price up.
                        0
                        • Do the Swiss not know Roche Covid-19 tests have been FDA approved? How is this dropping guys?
                          0
                          • Exactly im about to aggressively put 30% of my portfolio on this stock. I believe price may even more then double in the coming months to years.
                            0
                        • Long term.
                          0
                          • Turkish bank YAPI KREDI #ykbnk target 1,5 $
                            2
                            • Buy this stock @190, it's very good for long term..
                              1
                              • agreed... around 180/190 it will look ok.
                                0
                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.